Abstract
During duplication of the genome, eukaryotic cells may experience various exogenous and endogenous replication stresses that impede progression of DNA replication along chromosomes. Chemical alterations in template DNA, imbalances of deoxynucleotide pools, repetitive sequences, tight DNA–protein complexes, and conflict with transcription can negatively affect the replication machineries. If not properly resolved, stalled replication forks can cause chromosome breaks leading to genomic instability and tumor development. Replication stress is enhanced in cancer cells due, for example, to the loss of DNA repair genes or replication–transcription conflict caused by activation of oncogenic pathways. To prevent these serious consequences, cells are equipped with diverse mechanisms that enhance the resilience of replication machineries to replication stresses. This review describes DNA damage responses activated at stressed replication forks and summarizes current knowledge on the pathways that promote faithful chromosome replication and protect chromosome integrity, including ATR-dependent replication checkpoint signaling, DNA cross-link repair, and SLX4-mediated responses to tight DNA–protein complexes that act as barriers. This review also focuses on the relevance of replication stress responses to selective cancer chemotherapies.
Similar content being viewed by others
Availability of data and material
Not applicable.
References
Hills SA, Diffley JFX (2014) DNA replication and oncogene-induced replicative stress. Curr Biol 24:R435-444. https://doi.org/10.1016/j.cub.2014.04.012
Prioleau M, MacAlpine DM (2016) DNA replication origins—where do we begin? Genes Dev 30:1683–1697. https://doi.org/10.1101/gad.285114.116.ical
Ganier O, Prorok P, Akerman I, Méchali M (2019) Metazoan DNA replication origins. Curr Opin Cell Biol 58:134–141. https://doi.org/10.1016/j.ceb.2019.03.003
Masai H, Matsumoto S, You Z et al (2010) Eukaryotic chromosome DNA replication: where, when, and how? Annu Rev Biochem 79:89–130. https://doi.org/10.1146/annurev.biochem.052308.103205
Fragkos M, Ganier O, Coulombe P, Méchali M (2015) DNA replication origin activation in space and time. Nat Rev Mol Cell Biol 16:360–374. https://doi.org/10.1038/nrm4002
Fujita M (2006) Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells. Cell Div 1:22. https://doi.org/10.1186/1747-1028-1-22
Bleichert F, Botchan MR, Berger JM (2017) Mechanisms for initiating cellular DNA replication. Science 355:eaah6317. https://doi.org/10.1126/science.aah6317
Lewis JS, Costa A (2020) Caught in the act: structural dynamics of replication origin activation and fork progression. Biochem Soc Trans 48:1057–1066. https://doi.org/10.1042/BST20190998
Muñoz S, Méndez J (2017) DNA replication stress: from molecular mechanisms to human disease. Chromosoma 126:1–15. https://doi.org/10.1007/s00412-016-0573-x
García-Muse T, Aguilera A (2016) Transcription-replication conflicts: how they occur and how they are resolved. Nat Rev Mol Cell Biol 17:553–563. https://doi.org/10.1038/nrm.2016.88
Bertolin AP, Hoffmann JS, Gottifredi V (2020) Under-replicated DNA: the byproduct of large genomes? Cancers (Basel) 12:2764. https://doi.org/10.3390/cancers12102764
Tubbs A, Nussenzweig A (2017) Endogenous DNA damage as a source of genomic instability in cancer. Cell 168:644–656. https://doi.org/10.1016/j.cell.2017.01.002
Macheret M, Bhowmick R, Sobkowiak K et al (2020) High-resolution mapping of mitotic DNA synthesis regions and common fragile sites in the human genome through direct sequencing. Cell Res 30:997–1008. https://doi.org/10.1038/s41422-020-0358-x
Özer Ö, Hickson ID (2018) Pathways for maintenance of telomeres and common fragile sites during DNA replication stress. Open Biol 8:180018. https://doi.org/10.1098/rsob.180018
Debatisse M, Rosselli F (2019) A journey with common fragile sites: from S phase to telophase. Genes Chromosom Cancer 58:305–316. https://doi.org/10.1002/gcc.22704
Wu S, Turner KM, Nguyen N et al (2019) Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature 575:699–703. https://doi.org/10.1038/s41586-019-1763-5
Morton AR, Dogan-Artun N, Faber ZJ et al (2019) Functional enhancers shape extrachromosomal oncogene amplifications. Cell 179:1330–1341. https://doi.org/10.1016/j.cell.2019.10.039
Gu X, Yu J, Chai P et al (2020) Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression. J Exp Clin Cancer Res 39:215. https://doi.org/10.1186/s13046-020-01726-4
Kotsantis P, Petermann E, Boulton SJ (2018) Mechanisms of oncogene-induced replication stress: Jigsaw falling into place. Cancer Discov 8:537–555. https://doi.org/10.1158/2159-8290.CD-17-1461
Primo LMF, Teixeira LK (2020) DNA replication stress: oncogenes in the spotlight. Genet Mol Biol 43:e20190138. https://doi.org/10.1590/1678-4685gmb-2019-0138
Giannattasio M, Branzei D (2017) S-phase checkpoint regulations that preserve replication and chromosome integrity upon dNTP depletion. Cell Mol Life Sci 74:2361–2380. https://doi.org/10.1007/s00018-017-2474-4
Ercilla A, Benada J, Amitash S et al (2020) Physiological tolerance to ssDNA enables strand uncoupling during DNA replication. Cell Rep 30:2416–2429. https://doi.org/10.1016/j.celrep.2020.01.067
Cimprich KA, Cortez D (2008) ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 9:616–627. https://doi.org/10.1038/nrm2450
Saldivar JC, Cortez D, Cimprich KA (2017) The essential kinase ATR: ensuring faithful duplication of a challenging genome. Nat Rev Mol Cell Biol 18:622–636. https://doi.org/10.1038/nrm.2017.67
Blackford AN, Jackson SP (2017) ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell 66:801–817. https://doi.org/10.1016/j.molcel.2017.05.015
Lemmens B, Lindqvist A (2019) DNA replication and mitotic entry: A brake model for cell cycle progression. J Cell Biol 218:3892–3902. https://doi.org/10.1083/JCB.201909032
Saldivar JC, Hamperl S, Bocek MJ et al (2018) An intrinsic S/G2 checkpoint enforced by ATR. Science 361:806–810. https://doi.org/10.1126/science.aap9346
Toledo L, Neelsen KJ, Lukas J (2017) Replication catastrophe: when a checkpoint fails because of exhaustion. Mol Cell 66:735–749. https://doi.org/10.1016/j.molcel.2017.05.001
Zou L, Elledge SJ (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542–1548. https://doi.org/10.1126/science.1083430
Cortez D, Guntuku S, Qin J, Elledge SJ (2001) ATR and ATRIP: partners in checkpoint signaling. Science 294:1713–1716. https://doi.org/10.1126/science.1065521
Mordes DA, Glick GG, Zhao R, Cortez D (2008) TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. Genes Dev 22:1478–1489. https://doi.org/10.1101/gad.1666208
Kumagai A, Lee J, Yoo HY, Dunphy WG (2006) TopBP1 activates the ATR-ATRIP complex. Cell 124:943–955. https://doi.org/10.1016/j.cell.2005.12.041
Haahr P, Hoffmann S, Tollenaere MAX et al (2016) Activation of the ATR kinase by the RPA-binding protein ETAA1. Nat Cell Biol 18:1196–1207. https://doi.org/10.1038/ncb3422
Thada V, Cortez D (2021) ATR activation is regulated by dimerization of ATR activating proteins. J Biol Chem 296:100455. https://doi.org/10.1016/j.jbc.2021.100455
Bass TE, Luzwick JW, Kavanaugh G et al (2016) ETAA1 acts at stalled replication forks to maintain genome integrity. Nat Cell Biol 18:1185–1195. https://doi.org/10.1038/ncb3415
Lee YC, Zhou Q, Chen J, Yuan J (2016) RPA-binding protein ETAA1 is an ATR activator involved in DNA replication stress response. Curr Biol 26:3257–3268. https://doi.org/10.1016/j.cub.2016.10.030
Delacroix S, Wagner JM, Kobayashi M et al (2007) The Rad9-Hus1-Rad1 (9–1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev 21:1472–1477. https://doi.org/10.1101/gad.1547007
Lee J, Kumagai A, Dunphy WG (2007) The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR. J Biol Chem 282:28036–28044. https://doi.org/10.1074/jbc.M704635200
Ellison V, Stillman B (2003) Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5′ recessed DNA. PLoS Biol 1:e33. https://doi.org/10.1371/journal.pbio.0000033
Bermudez VP, Lindsey-Boltz LA, Cesare AJ et al (2003) Loading of the human 9–1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro. Proc Natl Acad Sci USA 100:1633–1638. https://doi.org/10.1073/pnas.0437927100
Zou L, Liu D, Elledge SJ (2003) Replication protein A-mediated recruitment and activation of Rad17 complexes. Proc Natl Acad Sci USA 100:13827–13832. https://doi.org/10.1073/pnas.2336100100
Frattini C, Promonet A, Alghoul E et al (2021) TopBP1 assembles nuclear condensates to switch on ATR signaling. Mol Cell 81:1231–1245. https://doi.org/10.1016/j.molcel.2020.12.049
Wardlaw CP, Carr AM, Oliver AW (2014) TopBP1: a BRCT-scaffold protein functioning in multiple cellular pathways. DNA Repair (Amst) 22:165–174. https://doi.org/10.1016/j.dnarep.2014.06.004
Lyu K, Kumagai A, Dunphy WG (2019) RPA-coated single-stranded DNA promotes the ETAA1-dependent activation of ATR. Cell Cycle 18:898–913. https://doi.org/10.1080/15384101.2019.1598728
Feng S, Zhao Y, Xu Y et al (2016) Ewing tumor-associated antigen 1 interacts with replication protein A to promote restart of stalled replication forks. J Biol Chem 291:21956–21962. https://doi.org/10.1074/jbc.C116.747758
Achuthankutty D, Thakur RS, Haahr P et al (2019) Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability. J Cell Biol 218:3943–3953. https://doi.org/10.1083/JCB.201905064
Bass TE, Cortez D (2019) Quantitative phosphoproteomics reveals mitotic function of the ATR activator ETAA1. J Cell Biol 218:1235–1249. https://doi.org/10.1083/jcb.201810058
Kabeche L, Nguyen HD, Buisson R, Zou L (2018) A mitosis-specific and R loop–driven ATR pathway promotes faithful chromosome segregation. Science 359:108–114. https://doi.org/10.1016/S1369-5274(01)00265-X
Miosge LA, Sontani Y, Chuah A et al (2017) Systems-guided forward genetic screen reveals a critical role of the replication stress response protein ETAA1 in T cell clonal expansion. Proc Natl Acad Sci USA 114:E5216–E5225. https://doi.org/10.1073/pnas.1705795114
Jeon Y, Ko E, Lee KY et al (2011) TopBP1 deficiency causes an early embryonic lethality and induces cellular senescence in primary cells. J Biol Chem 286:5414–5422. https://doi.org/10.1074/jbc.M110.189704
Zhou ZW, Liu C, Li TL et al (2013) An essential function for the ATR-Activation-Domain (AAD) of TopBP1 in mouse development and cellular senescence. PLoS Genet 9:e1003702. https://doi.org/10.1371/journal.pgen.1003702
Jones MJK, Gelot C, Munk S et al (2021) Human DDK rescues stalled forks and counteracts checkpoint inhibition at unfired origins to complete DNA replication. Mol Cell 81:426–441. https://doi.org/10.1016/j.molcel.2021.01.004
Dwivedi VK, Pardo-Pastor C, Droste R et al (2021) Replication stress promotes cell elimination by extrusion. Nature 593:591–596. https://doi.org/10.1038/s41586-021-03526-y
Xie M, Yen Y, Owonikoko TK et al (2014) Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase. Cancer Res 74:212–223. https://doi.org/10.1158/0008-5472.CAN-13-1536-T
Aird KM, Zhang G, Li H et al (2013) Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep 3:1252–1265. https://doi.org/10.1016/j.celrep.2013.03.004
Bester AC, Roniger M, Oren YS et al (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145:435–446. https://doi.org/10.1016/j.cell.2011.03.044
Poli J, Tsaponina O, Crabbé L et al (2012) dNTP pools determine fork progression and origin usage under replication stress. EMBO J 31:883–894. https://doi.org/10.1038/emboj.2011.470
Lopez-Contreras AJ, Specks J, Barlow JH et al (2015) Increased Rrm2 gene dosage reduces fragile site breakage and prolongs survival of ATR mutant mice. Genes Dev 29:690–695. https://doi.org/10.1101/gad.256958.114
Shu Z, Li Z, Huang H et al (2020) Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition. Oncogene 39:5721–5733. https://doi.org/10.1038/s41388-020-01403-y
Neelsen KJ, Lopes M (2015) Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat Rev Mol Cell Biol 16:207–220. https://doi.org/10.1038/nrm3935
Cortez D (2019) Replication-coupled DNA repair. Mol Cell 74:866–876. https://doi.org/10.1016/j.molcel.2019.04.027
Berti M, Cortez D, Lopes M (2020) The plasticity of DNA replication forks in response to clinically relevant genotoxic stress. Nat Rev Mol Cell Biol 21:633–651. https://doi.org/10.1038/s41580-020-0257-5
Rickman K, Smogorzewska A (2019) Advances in understanding DNA processing and protection at stalled replication forks. J Cell Biol 218:1096–1107. https://doi.org/10.1083/jcb.201809012
Coquel F, Silva MJ, Técher H et al (2018) SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature 557:57–61. https://doi.org/10.1038/s41586-018-0050-1
Taylor MRG, Yeeles JTP (2018) The initial response of a eukaryotic replisome to DNA damage. Mol Cell 70:1067–1080. https://doi.org/10.1016/j.molcel.2018.04.022
Taylor MRG, Yeeles JTP (2019) Dynamics of replication fork progression following helicase-polymerase uncoupling in eukaryotes. J Mol Biol 431:2040–2049. https://doi.org/10.1016/j.jmb.2019.03.011
Berti M, Vindigni A (2016) Replication stress: getting back on track. Nat Struct Mol Biol 23:103–109. https://doi.org/10.1038/nsmb.3163
Sale JE (2013) Translesion DNA synthesis and mutagenesis in prokaryotes. Cold Spring Harb Perspect Biol 5:a012708. https://doi.org/10.1101/cshperspect.a012682
Quinet A, Tirman S, Cybulla E et al (2021) Review to skip or not to skip: choosing repriming to tolerate DNA damage. Mol Cell 81:649–658. https://doi.org/10.1016/j.molcel.2021.01.012
Guilliam TA, Yeeles JTP (2020) Reconstitution of translesion synthesis reveals a mechanism of eukaryotic DNA replication restart. Nat Struct Mol Biol 27:450–460. https://doi.org/10.1038/s41594-020-0418-4
Liao H, Ji F, Helleday T, Ying S (2018) Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments. EMBO Rep 19:e46263. https://doi.org/10.15252/embr.201846263
Wong RP, García-Rodríguez N, Zilio N et al (2020) Processing of DNA polymerase-blocking lesions during genome replication is spatially and temporally segregated from replication forks. Mol Cell 77:3–16. https://doi.org/10.1016/j.molcel.2019.09.015
Brosh RM Jr (2013) DNA helicases involved in DNA repair and their roles in cancer. Nat Rev Cancer 13:542–558. https://doi.org/10.1038/nrc3560.DNA
Duxin JP, Walter JC (2015) What is the DNA repair defect underlying Fanconi anemia? Curr Opin Cell Biol 37:49–60. https://doi.org/10.1016/j.ceb.2015.09.002
Dingler FA, Wang M, Mu A et al (2020) Two aldehyde clearance systems are essential to prevent lethal formaldehyde accumulation in mice and humans. Mol Cell 80:996–1012. https://doi.org/10.1016/j.molcel.2020.10.012
Pontel LB, Rosado IV, Burgos-Barragan G et al (2015) Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen. Mol Cell 60:177–188. https://doi.org/10.1016/j.molcel.2015.08.020
Rosado IV, Langevin F, Crossan GP et al (2011) Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat Struct Mol Biol 18:1432–1434. https://doi.org/10.1038/nsmb.2173
Garaycoechea JI, Crossan GP, Langevin F et al (2012) Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489:571–575. https://doi.org/10.1038/nature11368
Langevin F, Crossan GP, Rosado IV et al (2011) Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 475:53–59. https://doi.org/10.1038/nature10192
Hira A, Yabe H, Yoshida K et al (2013) Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 122:3206–3209. https://doi.org/10.1182/blood-2013-06-507962
Bin FC, Wu HT, Zhang ML et al (2020) Fanconi anemia pathway: mechanisms of breast cancer predisposition development and potential therapeutic targets. Front Cell Dev Biol 8:160. https://doi.org/10.3389/fcell.2020.00160
Michl J, Zimmer J, Tarsounas M (2016) Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J 35:909–923. https://doi.org/10.15252/embj.201693860
Ceccaldi R, Sarangi P, D’Andrea AD (2016) The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol 17:337–349. https://doi.org/10.1038/nrm.2016.48
Datta A, Brosh RM (2019) Holding all the cards—how Fanconi anemia proteins deal with replication stress and preserve genomic stability. Genes (Basel) 10:170. https://doi.org/10.3390/genes10020170
Niraj J, Färkkilä A, D’Andrea AD (2019) The Fanconi anemia pathway in cancer. Annu Rev Cancer Biol 3:457–478. https://doi.org/10.1146/annurev-cancerbio-030617-050422
Semlow DR, Walter JC (2021) Mechanisms of vertebrate DNA interstrand cross-link repair. Annu Rev Biochem 90:107–135. https://doi.org/10.1146/annurev-biochem-080320-112510
Räschle M, Knipsheer P, Enoiu M et al (2008) Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 134:969–980. https://doi.org/10.1016/j.cell.2008.08.030
Wu RA, Pellman DS, Walter JC (2021) The ubiquitin ligase TRAIP: double-edged sword at the replisome. Trends Cell Biol 31:75–85. https://doi.org/10.1016/j.tcb.2020.11.007
Wu RA, Semlow DR, Kamimae-Lanning AN et al (2019) TRAIP is a master regulator of DNA interstrand crosslink repair. Nature 567:267–272. https://doi.org/10.1038/s41586-019-1002-0
Fullbright G, Rycenga HB, Gruber JD, Long DT (2016) p97 Promotes a conserved mechanism of helicase unloading during DNA cross-link repair. Mol Cell Biol 36:2983–2994. https://doi.org/10.1128/mcb.00434-16
Zhang J, Dewar JM, Budzowska M et al (2015) DNA interstrand cross-link repair requires replication-fork convergence. Nat Struct Mol Biol 22:242–247. https://doi.org/10.1038/nsmb.2956
Knipscheer P, Räschle M, Smogorzewska A et al (2009) The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science 326:1698–1701. https://doi.org/10.1126/science.1182372
Zhang J, Walter JC (2014) Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair (Amst) 19:135–142. https://doi.org/10.1016/j.dnarep.2014.03.018
Wang R, Wang S, Dhar A et al (2020) DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex. Nature 580:278–282. https://doi.org/10.1038/s41586-020-2110-6
Alcón P, Shakeel S, Chen ZA et al (2020) FANCD2–FANCI is a clamp stabilized on DNA by monoubiquitination of FANCD2 during DNA repair. Nat Struct Mol Biol 27:240–248. https://doi.org/10.1038/s41594-020-0380-1
Klein Douwel D, Boonen RACM, Long DT et al (2014) XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Mol Cell 54:460–471. https://doi.org/10.1016/j.molcel.2014.03.015
Yamamoto KN, Kobayashi S, Tsuda M et al (2011) Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway. Proc Natl Acad Sci USA 108:6492–6496. https://doi.org/10.1073/pnas.1018487108
Wang AT, Sengerová B, Cattell E et al (2011) Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. Genes Dev 25:1859–1870. https://doi.org/10.1101/gad.15699211
Hoogenboom WS, Boonen RACM, Knipscheer P (2019) The role of SLX4 and its associated nucleases in DNA interstrand crosslink repair. Nucleic Acids Res 47:2377–2388. https://doi.org/10.1093/nar/gky1276
Baddock HT, Yosaatmadja Y, Newman JA et al (2020) The SNM1A DNA repair nuclease. DNA Repair (Amst) 95:102941. https://doi.org/10.1016/j.dnarep.2020.102941
Amunugama R, Willcox S, Wu RA et al (2018) Replication fork reversal during DNA interstrand crosslink repair requires CMG unloading. Cell Rep 23:3419–3428. https://doi.org/10.1016/j.celrep.2018.05.061
Sabatella M, Pines A, Slyskova J et al (2020) ERCC1–XPF targeting to psoralen–DNA crosslinks depends on XPA and FANCD2. Cell Mol Life Sci 77:2005–2016. https://doi.org/10.1007/s00018-019-03264-5
Lachaud C, Castor D, Hain K et al (2014) Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia. J Cell Sci 127:2811–2817. https://doi.org/10.1242/jcs.146167
Semlow DR, Zhang J, Budzowska M et al (2016) Replication-dependent unhooking of DNA interstrand cross-links by the NEIL3 glycosylase. Cell 167:498–511. https://doi.org/10.1016/j.cell.2016.09.008
Li N, Wang J, Wallace SS et al (2020) Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair. Nucleic Acids Res 48:3014–3028. https://doi.org/10.1093/nar/gkaa038
Hodskinson MR, Bolner A, Sato K et al (2020) Alcohol-derived DNA crosslinks are repaired by two distinct mechanisms. Nature 579:603–608. https://doi.org/10.1038/s41586-020-2059-5
Jacome A, Fernandez-Capetillo O (2011) Lac operator repeats generate a traceable fragile site in mammalian cells. EMBO Rep 12:1032–1038. https://doi.org/10.1038/embor.2011.158
Ishimoto R, Tsuzuki Y, Matsumura T et al (2021) SLX4–XPF mediates DNA damage responses to replication stress induced by DNA–protein interactions. J Cell Biol 220:e202003148. https://doi.org/10.1083/jcb.202003148
Kim J, Sturgill D, Sebastian R et al (2018) Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions. Mol Cell 69:36–47. https://doi.org/10.1016/j.molcel.2017.11.021
Beuzer P, Quivy JP, Almouzni G (2014) Establishment of a replication fork barrier following induction of DNA binding in mammalian cells. Cell Cycle 13:1607–1616. https://doi.org/10.4161/cc.28627
Hizume K, Endo S, Muramatsu S et al (2018) DNA polymerase ε-dependent modulation of the pausing property of the CMG helicase at the barrier. Genes Dev 32:1315–1320. https://doi.org/10.1101/gad.317073.118
Hanamshet K, Mazina OM, Mazin AV (2016) Reappearance from obscurity: mammalian Rad52 in homologous recombination. Genes (Basel) 7:63. https://doi.org/10.3390/genes7090063
Niedernhofer LJ, Lalai AS, Hoeijmakers JHJ (2005) Fanconi anemia (cross)linked to DNA repair. Cell 123:1191–1198. https://doi.org/10.1016/j.cell.2005.12.009
Huang JW, Acharya A, Taglialatela A et al (2020) MCM8IP activates the MCM8-9 helicase to promote DNA synthesis and homologous recombination upon DNA damage. Nat Commun 11:2948. https://doi.org/10.1038/s41467-020-16718-3
Hustedt N, Saito Y, Zimmermann M et al (2019) Control of homologous recombination by the HROB-MCM8-MCM9 pathway. Genes Dev 33:1397–1415. https://doi.org/10.1101/gad.329508.119
Lutzmann M, Grey C, Traver S et al (2012) MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination. Mol Cell 47:523–534. https://doi.org/10.1016/j.molcel.2012.05.048
Nishimura K, Ishiai M, Horikawa K et al (2012) Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks. Mol Cell 47:511–522. https://doi.org/10.1016/j.molcel.2012.05.047
Park J, Long DT, Lee KY et al (2013) The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination. Mol Cell Biol 33:1632–1644. https://doi.org/10.1128/mcb.01503-12
Natsume T, Nishimura K, Minocherhomji S et al (2017) Acute inactivation of the replicative helicase in human cells triggers MCM8–9-dependent DNA synthesis. Genes Dev 31:816–829. https://doi.org/10.1101/gad.297663.117
Morii I, Iwabuchi Y, Mori S et al (2019) Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib. Cancer Sci 110:1044–1053. https://doi.org/10.1111/cas.13941
Li S, Wang H, Jehi S et al (2021) PIF1 helicase promotes break-induced replication in mammalian cells. EMBO J 40:104509. https://doi.org/10.15252/embj.2020104509
Mutreja K, Krietsch J, Hess J et al (2018) ATR-mediated global fork slowing and reversal assist fork traverse and prevent chromosomal breakage at DNA interstrand cross-links. Cell Rep 24:2629–2642. https://doi.org/10.1016/j.celrep.2018.08.019
Huang J, Zhang J, Bellani MA et al (2019) Remodeling of interstrand crosslink proximal replisomes is dependent on ATR, FANCM, and FANCD2. Cell Rep 27:1794–1808. https://doi.org/10.1016/j.celrep.2019.04.032
Huang J, Liu S, Bellani MA et al (2013) The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks. Mol Cell 52:434–446. https://doi.org/10.1016/j.molcel.2013.09.021
Bellani MA, Huang J, Paramasivam M et al (2018) Imaging cellular responses to antigen tagged DNA damage. DNA Repair (Amst) 71:183–189. https://doi.org/10.1016/j.dnarep.2018.08.023
Gaillard H, García-Muse T, Aguilera A (2015) Replication stress and cancer. Nat Rev Cancer 15:276–280. https://doi.org/10.1038/nrc3916
Kitao H, Iimori M, Kataoka Y et al (2018) DNA replication stress and cancer chemotherapy. Cancer Sci 109:264–271. https://doi.org/10.1111/cas.13455
Kotsantis P, Silva LM, Irmscher S et al (2016) Increased global transcription activity as a mechanism of replication stress in cancer. Nat Commun 7:13087. https://doi.org/10.1038/ncomms13087
Macheret M, Halazonetis TD (2018) Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress. Nature 555:112–116. https://doi.org/10.1038/nature25507
Motegi A, Masutani M, Yoshioka K, Bessho T (2019) Aberrations in DNA repair pathways in cancer and therapeutic significances. Semin Cancer Biol 58:29–46. https://doi.org/10.1016/j.semcancer.2019.02.005
Gilad O, Nabet BY, Ragland RL et al (2010) Combining ATR suppression with oncogenic ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Res 70:9693–9702. https://doi.org/10.1158/0008-5472.CAN-10-2286
Murga M, Campaner S, Lopez-Contreras AJ et al (2011) Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol 18:1331–1335. https://doi.org/10.1038/nsmb.2189
Toledo LI, Murga M, Zur R et al (2011) A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat Struct Mol Biol 18:721–727. https://doi.org/10.1038/nsmb.2076
Schoppy DW, Ragland RL, Gilad O et al (2012) Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. J Clin Invest 122:241–252. https://doi.org/10.1172/JCI58928
Lecona E, Fernandez-Capetillo O (2018) Targeting ATR in cancer. Nat Rev Cancer 18:586–595. https://doi.org/10.1038/s41568-018-0034-3
Karnitz LM, Zou L (2015) Molecular pathways: targeting ATR in cancer therapy. Clin Cancer Res 21:4780–4785. https://doi.org/10.1158/1078-0432.CCR-15-0479
Ubhi T, Brown GW (2019) Exploiting DNA replication stress for cancer treatment. Cancer Res 79:1730–1739. https://doi.org/10.1158/0008-5472.CAN-18-3631
Hong D, Infante J, Janku F et al (2016) Phase i study of LY2606368, a checkpoint kinase 1 inhibitor, in patients with advanced cancer. J Clin Oncol 34:1764–1771. https://doi.org/10.1200/JCO.2015.64.5788
Young LA, O’Connor LO, de Renty C et al (2019) Differential activity of ATR and Wee1 inhibitors in a highly sensitive subpopulation of DLBCL linked to replication stress. Cancer Res 79:3762–3775. https://doi.org/10.1158/0008-5472.CAN-18-2480
Jin J, Fang H, Yang F et al (2018) Combined inhibition of ATR and WEE1 as a novel therapeutic strategy in triple-negative breast cancer. Neoplasia 20:478–488. https://doi.org/10.1016/j.neo.2018.03.003
Fragkos M, Naim V (2017) Rescue from replication stress during mitosis. Cell Cycle 16:613–633. https://doi.org/10.1080/15384101.2017.1288322
Wilhelm T, Olziersky AM, Harry D et al (2019) Mild replication stress causes chromosome mis-segregation via premature centriole disengagement. Nat Commun 10:3585. https://doi.org/10.1038/s41467-019-11584-0
Masamsetti VP, Low RRJ, Mak KS et al (2019) Replication stress induces mitotic death through parallel pathways regulated by WAPL and telomere deprotection. Nat Commun 10:4224. https://doi.org/10.1038/s41467-019-12255-w
Acknowledgements
We apologize to our colleagues whose work we were unable to cite due to space limitations. We thank members of the Fujita lab for helpful discussions and comments on the manuscript.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
KY and MF wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no potential conflicts of interest.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yoshida, K., Fujita, M. DNA damage responses that enhance resilience to replication stress. Cell. Mol. Life Sci. 78, 6763–6773 (2021). https://doi.org/10.1007/s00018-021-03926-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-021-03926-3